scriptaid has been researched along with Cancer of Endometrium in 2 studies
scriptide: provokes translocation of GLUT4 to increase glucose uptake; structure in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "Although the early-stage endometrial cancer can be effectively managed with surgery, more advanced stages of the disease require multimodality treatment with varying results." | 2.58 | Targeting histone deacetylases in endometrial cancer: a paradigm-shifting therapeutic strategy? ( Alavanos, A; Andreatos, N; Angelou, A; Antoniou, EA; Apostolou, KG; Athanasiou, A; Damaskos, C; Damaskou, Z; Daskalopoulou, A; Diamantis, E; Dimitroulis, D; Garmpi, A; Garmpis, N; Kalampokas, E; Kalampokas, T; Kontzoglou, K; Kostakis, A; Lavaris, A; Mantas, D; Margonis, GA; Markatos, K; Moschos, MM; Nikiteas, N; Nonni, A; Perrea, D; Sampani, A; Schizas, D; Spartalis, E; Spartalis, M; Tsivelekas, K; Tsourouflis, G; Valsami, S, 2018) |
| "Endometrial and ovarian cancer cells were treated with various concentrations of Scriptaid, and its effect on cell growth, cell cycle, apoptosis, and related measurements was investigated." | 1.33 | A novel histone deacetylase inhibitor, Scriptaid, induces growth inhibition, cell cycle arrest and apoptosis in human endometrial cancer and ovarian cancer cells. ( Narahara, H; Nasu, K; Nishida, M; Takai, N; Ueda, T, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garmpis, N | 1 |
| Damaskos, C | 1 |
| Garmpi, A | 1 |
| Spartalis, E | 1 |
| Kalampokas, E | 1 |
| Kalampokas, T | 1 |
| Margonis, GA | 1 |
| Schizas, D | 1 |
| Andreatos, N | 1 |
| Angelou, A | 1 |
| Lavaris, A | 1 |
| Athanasiou, A | 1 |
| Apostolou, KG | 1 |
| Spartalis, M | 1 |
| Damaskou, Z | 1 |
| Daskalopoulou, A | 1 |
| Diamantis, E | 1 |
| Tsivelekas, K | 1 |
| Alavanos, A | 1 |
| Valsami, S | 1 |
| Moschos, MM | 1 |
| Sampani, A | 1 |
| Nonni, A | 1 |
| Antoniou, EA | 1 |
| Mantas, D | 1 |
| Tsourouflis, G | 1 |
| Markatos, K | 1 |
| Kontzoglou, K | 1 |
| Perrea, D | 1 |
| Nikiteas, N | 1 |
| Kostakis, A | 1 |
| Dimitroulis, D | 1 |
| Takai, N | 1 |
| Ueda, T | 1 |
| Nishida, M | 1 |
| Nasu, K | 1 |
| Narahara, H | 1 |
1 review available for scriptaid and Cancer of Endometrium
| Article | Year |
|---|---|
Targeting histone deacetylases in endometrial cancer: a paradigm-shifting therapeutic strategy?
Topics: Antineoplastic Agents; Endometrial Neoplasms; Endometrium; Female; Histone Deacetylase Inhibitors; H | 2018 |
1 other study available for scriptaid and Cancer of Endometrium
| Article | Year |
|---|---|
A novel histone deacetylase inhibitor, Scriptaid, induces growth inhibition, cell cycle arrest and apoptosis in human endometrial cancer and ovarian cancer cells.
Topics: Annexin A5; Apoptosis; Cell Cycle; Cell Line, Tumor; Endometrial Neoplasms; Enzyme Inhibitors; Epith | 2006 |